Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study for Patients with cMET-Dependent Cancers to Continue Treatment with Capmatinib, Nazartinib, and Gefitinib

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Belgium Germany Italy
  • Study of SKB264 for Patients with Advanced Solid Tumors Not Responding to Standard Treatments

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Italy Spain
  • Study on the Effects of Selpercatinib in Children with Advanced RET-Altered Solid Tumors or Primary Central Nervous System Tumors

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    Denmark France Germany Italy Spain
  • Screening for Hidden Cancer Using FDG PET/CT and Gallium (68Ga) Chloride in Patients Aged 50+ with Unexplained Blood Clots

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on the Safety and Anti-tumor Effects of GEN1042 Alone or with Pembrolizumab and Chemotherapy in Patients with Advanced Solid Tumors

    Not recruiting

    2 1 1 1
    Denmark France Germany Italy Spain
  • A Phase 1/2a Study of BNT142 Safety and Early Effectiveness in Patients with Advanced Solid Tumors Expressing CLDN6 Protein

    Not recruiting

    2 1 1
    Germany The Netherlands Spain
  • Study on the Safety and Effects of Vimseltinib for Patients with Advanced Tumors and Tenosynovial Giant Cell Tumor

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Italy The Netherlands Poland Spain
  • Study of Sacituzumab Govitecan for Patients with Metastatic Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Spain
  • Study on the Effectiveness of Autologous Tumor-Infiltrating Lymphocytes, Aldesleukin, Fludarabine Phosphate, and Cyclophosphamide in Advanced Solid Tumors

    Not recruiting

    2 1 1 1
    Spain
  • Study on the Safety and Effectiveness of BLU-222 Alone and with Drug Combination for Patients with Advanced Solid Tumors, Including Breast and Ovarian Cancer

    Not recruiting

    2 1 1 1
    Belgium France Italy Spain